Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Beko Calls for Climate, Trade, and Finance Policies to Align as Carbon Rules Reshape Manufacturing

Fatih Özkadı and Barış Alparslan set out the company's case for competitive, lower-carbon value chains and the capital needed to build them. ANTALYA, Türkiye, Nov....

uSMART Securities Singapore Marks Third Branch Opening in Bugis with Lion Dance and K-pop

SINGAPORE, Nov. 14, 2026 /PRNewswire/ -- uSMART Securities Singapore officially opened its third branch...
Cision PR Newswire

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB;...
Cision PR Newswire

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Cision PR Newswire

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...
Cision PR Newswire

BNI Unifies Global Trade Finance on Finastra’s Trade Innovation, significantly accelerating customer onboarding

Centralized...

Cosmo Announces Leadership Transition; Mark Griffie appointed as Chief Executive Officer

SINGAPORE and BOSTON, Jan. 13, 2026 /PRNewswire/ -- Cosmo, a global leader in performance textiles, composites, and advanced materials for the footwear and apparel...

Entering Its 16th Year: Vantage Markets Sets a New Standard for the “Ultimate Trading Machine”

PORT...

aulumu Showcases High-Performance Design Philosophy at CES 2026 with G09 and M10

LAS VEGAS, Jan. 13, 2026 /PRNewswire/ -- During CES 2026, aulumu, a design brand focused on high-performance gear, drew attention by showcasing a range of...

Delta Recognized by CDP with Double “A” Leadership Rating for Climate Change and Water Security for the Fifth Time

TAIPEI, Jan. 13, 2026 /PRNewswire/ -- Delta, a global leader in power management and smart green solutions, has been awarded double "A List" stature...

Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in...

SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from...
1...1,5321,5331,534...4,530Page 1,533 of 4,530